Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Patients With Non-Alcoholic Steatohepatitis

NCT04171765 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT04171765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04171765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Randomized, Parallel-Group, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of BFKB8488A Compared With Placebo in Patients With Non-Alcoholic Steatohepatitis
Lead sponsor
Genentech, Inc.
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2020
Completion date
January 23, 2023
Enrollment
46 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

non-alcoholic steatohepatitis